TRANSFREEMATION IVS: Financial statements 2018
CVR: 37192341
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
TRANSFREEMATION IVS (CVR 37192341) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 23,461 and a net result of DKK -201 compared with DKK 10,107 the year before. That is a decrease of 57.2% compared with the year before. The profit margin was -0.9%. Equity in the 2018 report amounted to DKK 6,803. The solvency ratio was 23.4%.
- Revenue
- DKK 23,461
- Gross Profit
- DKK 15,115
- Profit/Loss
- DKK -201
- Equity
- DKK 6,803
- Total Assets
- DKK 29,046
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
TRANSFREEMATION IVS has published its annual report for 2017. Revenue came to DKK 54,762, and the net result was DKK 10,107.
As of April 1, 2018, Stine Kjær Pilgaard is registered as director of TRANSFREEMATION IVS.
As of March 31, 2018, Aaron Michael Isley has stepped down as adm. dir. of TRANSFREEMATION IVS.
About TRANSFREEMATION IVS
TRANSFREEMATION IVS was a Danish company of the type Iværksætterselskab based in Vodskov, founded in 2015. The company has been dissolved on 1 April 2022. The company was registered under the industry Anden undervisning i.a.n.. In 2020, the company reported revenue of DKK 9,446 and a net result of DKK -23,681 compared with DKK 6,459 the year before. Equity in the 2020 report amounted to DKK -10,419.